Stem Cell Reports · 2020 · 39 citations · 31 references
Veterinary MedicineClinical SciencesInfectious DiseasesCell TherapyInflammationMolecular VirologyAcute Respiratory Distress SyndromeInflammation In Infectious DiseaseMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyPulmonary InflammationViral InfectionsAcute Respiratory Distress Syndrome InflammationAdipose-derived Mesenchymal Stromal CellsBone Marrow-derived Mesenchymal Stromal CellsCovid-19-associated Acute Respiratory Distress SyndromeIndoleamine 2, 3-Dioxygenase PathwayMesenchymal Stromal Cell EngraftmentProgenitor CellsSars-cov-2 Infection
Previous studies reported on the safety and applicability of mesenchymal stem/stromal cells (MSCs) to ameliorate pulmonary inflammation in acute respiratory distress syndrome (ARDS). Thus, multiple clinical trials assessing the potential of MSCs for COVID-19 treatment are underway. Yet, as SARS-inducing coronaviruses infect stem/progenitor cells, it is unclear whether MSCs could be infected by SARS-CoV-2 upon transplantation to COVID-19 patients. We found that MSCs from bone marrow, amniotic fluid, and adipose tissue carry angiotensin-converting enzyme 2 and transmembrane protease serine subtype 2 at low levels on the cell surface under steady-state and inflammatory conditions. We did not observe SARS-CoV-2 infection or replication in MSCs at steady state under inflammatory conditions, or in direct contact with SARS-CoV-2-infected Caco-2 cells. Further, indoleamine 2,3-dioxygenase 1 production in MSCs was not impaired in the presence of SARS-CoV-2. We show that MSCs are resistant to SARS-CoV-2 infection and retain their immunomodulation potential, supporting their potential applicability for COVID-19 treatment.
31
Global quantification of mammalian gene expression control
Björn Schwanhäußer, Dorothea Busse, Na Li et al. · Nature · 2011 · 6.9K citations
Carly G.K. Ziegler, Samuel J. Allon, Sarah K. Nyquist et al. · Cell · 2020 · 2.5K citations · Full text
Isolation of amniotic stem cell lines with potential for therapy
Paolo De Coppi, Georg Bartsch, Mohummad Minhaj Siddiqui et al. · Nature Biotechnology · 2007 · 1.9K citations